Related Impurities Assessment Considerations for APIs in the Generic Complex Peptide Products


Manivannan Ethirajan from the Office of New Drug Products (ONDP) in the Office of Pharmaceutical Quality outlines the specification considerations for …

Leave a Reply

Your email address will not be published. Required fields are marked *